Lynelle Baumgardner Hoch
Direktor/Vorstandsmitglied bei Bristol-Myers Squibb Pharmaceuticals Ltd.
Ursprung des Netzwerks ersten Grades von Lynelle Baumgardner Hoch
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Celgene Ltd.
Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lynelle Baumgardner Hoch
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Celgene SRL (Belgium)
Celgene SRL (Belgium) Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Celgene SRL (Belgium) is a Belgian company that engages in research and development on biotechnology. The company is based in Watermaal-Bosvoorde, Belgium. The CEOs are Katherine Reynolds Kelly, David Walter Pignolet. The company was founded in 2006. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Secretary | |
Society for Corporate Governance, Inc.
Society for Corporate Governance, Inc. Miscellaneous Commercial ServicesCommercial Services Society for Corporate Governance, Inc. engages in providing advisory services and providing professional development and education through seminars and conferences in corporate governance area. The company was founded in 1946 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Bristol-Myers Squibb Holdings 2002 Ltd.
Bristol-Myers Squibb Holdings 2002 Ltd. Medical DistributorsDistribution Services Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings 2002 Ltd. is a holding British company that operates subsidiaries distributing and selling pharmaceutical products. The company is based in Uxbridge, UK. | Medical Distributors | Director/Board Member | |
CELGENE | Biotechnology | Director/Board Member | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Corporate Secretary | |
JUNO THERAPEUTICS INC | Biotechnology | Corporate Secretary | |
Juno Therapeutics GmbH
Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Biotechnology | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 7 |
Belgien | 2 |
Frankreich | 2 |
Vereinigtes Königreich | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 8 |
Commercial Services | 3 |
Distribution Services | 2 |
Operativ
Director/Board Member | 8 |
Corporate Secretary | 5 |
Chief Executive Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Lynelle Baumgardner Hoch
- Unternehmensverbindungen